| gptkbp:instanceOf | gptkb:biotechnology 
 | 
                        
                            
                                | gptkbp:acquiredBy | gptkb:The_Medicines_Company gptkb:Alcon
 gptkb:AveXis
 gptkb:Chiron_Corporation
 gptkb:Endocyte
 
 | 
                        
                            
                                | gptkbp:CEO | gptkb:Vas_Narasimhan 
 | 
                        
                            
                                | gptkbp:chairman | gptkb:Joerg_Reinhardt 
 | 
                        
                            
                                | gptkbp:country | gptkb:Switzerland 
 | 
                        
                            
                                | gptkbp:divested | gptkb:Sandoz_(2023) 
 | 
                        
                            
                                | gptkbp:founded | 1996 
 | 
                        
                            
                                | gptkbp:foundedBy | gptkb:Sandoz gptkb:Ciba-Geigy
 
 | 
                        
                            
                                | gptkbp:headquartersLocation | gptkb:Basel,_Switzerland 
 | 
                        
                            
                                | gptkbp:industry | Pharmaceuticals 
 | 
                        
                            
                                | gptkbp:ISIN | CH0012005267 
 | 
                        
                            
                                | gptkbp:legalForm | gptkb:company 
 | 
                        
                            
                                | gptkbp:logo | Novartis logo.svg 
 | 
                        
                            
                                | gptkbp:marketCap | $200+ billion (2024) 
 | 
                        
                            
                                | gptkbp:memberOf | gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
 
 | 
                        
                            
                                | gptkbp:netIncome | $7.047 billion (2023) 
 | 
                        
                            
                                | gptkbp:notableProduct | gptkb:Gleevec gptkb:Afinitor
 gptkb:Cosentyx
 gptkb:Diovan
 gptkb:Entresto
 gptkb:Exforge
 gptkb:Exjade
 gptkb:Galvus
 gptkb:Ilaris
 gptkb:Jakavi
 gptkb:Kymriah
 gptkb:Lucentis
 gptkb:Mekinist
 gptkb:Promacta
 gptkb:Rydapt
 gptkb:Sandostatin
 gptkb:Tafinlar
 gptkb:Tasigna
 gptkb:Voltaren
 gptkb:Zolgensma
 gptkb:Inclisiran
 gptkb:Adakveo
 gptkb:Beovu
 gptkb:Kesimpta
 gptkb:Leqvio
 gptkb:Mayzent
 gptkb:Piqray
 gptkb:Scemblix
 gptkb:Tabrecta
 
 | 
                        
                            
                                | gptkbp:numberOfEmployees | 101703 
 | 
                        
                            
                                | gptkbp:numberOfLocations | over 140 countries 
 | 
                        
                            
                                | gptkbp:officialLanguage | gptkb:French gptkb:German
 gptkb:Italian
 English
 
 | 
                        
                            
                                | gptkbp:parentCompany | None (independent) 
 | 
                        
                            
                                | gptkbp:products | Pharmaceutical drugs Generic drugs
 Biosimilars
 
 | 
                        
                            
                                | gptkbp:revenue | $50.545 billion (2023) 
 | 
                        
                            
                                | gptkbp:servesArea | Worldwide 
 | 
                        
                            
                                | gptkbp:stockExchange | gptkb:New_York_Stock_Exchange gptkb:SIX_Swiss_Exchange
 
 | 
                        
                            
                                | gptkbp:stockSymbol | gptkb:NOVN gptkb:NVS
 
 | 
                        
                            
                                | gptkbp:subsidiary | gptkb:Sandoz_(until_2023) 
 | 
                        
                            
                                | gptkbp:type | gptkb:public_company 
 | 
                        
                            
                                | gptkbp:website | https://www.novartis.com/ 
 | 
                        
                            
                                | gptkbp:bfsParent | gptkb:Srikant_M._Datar gptkb:NOVN
 gptkb:Novartis_Campus_landscape
 
 | 
                        
                            
                                | gptkbp:bfsLayer | 7 
 | 
                        
                            
                                | https://www.w3.org/2000/01/rdf-schema#label | Novartis AG 
 |